![](/img/cover-not-exists.png)
Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study
Beglinger, Christoph, Hu, Ke, Wang, Ying, Bouillaud, Emmanuel, Darstein, Christelle, Wang, Yanfeng, Mohideen, PharisVolume:
42
Language:
english
Journal:
Endocrine
DOI:
10.1007/s12020-012-9668-1
Date:
October, 2012
File:
PDF, 477 KB
english, 2012